VETERINARY ANTIBIOTICS MARKET ANALYSIS

Veterinary Antibiotics Market, By Drug Type (Aminoglycosides, ß-Lactam Antibiotics, Chloramphenicol, Fluoroquinolones, Glycopeptides, Lincosamides, Macrolides, Polymixins, Tetracyclines, and Others), By Dosage Form (Powder, Solutions, Injections, and Others), By Animal Type (Companion and Livestock), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On October 29, 2024, the Union Ministry of Animal Husbandry, part of the Government of India, introduced the Standard Veterinary Treatment Guidelines (SVTG) aimed at reducing and regulating antibiotic use for treating diseases in livestock and poultry. The guidelines also advocate for the incorporation of Ayurvedic medicines in veterinary care.
On April 10, 2024, Elanco Animal Health Incorporated, an animal health company, announced that the U.S. Food and Drug Administration had approved Pradalex (pradofloxacin injection) for treating certain respiratory diseases in cattle and swine. Pradofloxacin is a crucial antimicrobial in the fluoroquinolone class and can only be prescribed by licensed veterinarians as a single injection.
On February 14, 2024, Blacksmith Medicines, Inc., a biopharmaceutical company focused on discovering and developing medicines that target metalloenzymes, announced a collaboration with Zoetis, an animal health company. This partnership aims to discover and develop novel antibiotics for improving animal health.
On June 11, 2023, the U.S. Food and Drug Administration (FDA) implemented a significant transition of over-the-counter (OTC) medically important antimicrobials for animals to prescription status. This change, guided by GFI #263, aims to enhance antimicrobial stewardship by ensuring that these medications are used under the supervision of licensed veterinarians